Bingze Xu

1.6k citations
39 papers · 1.0k indexed · h-index 20
Topics
Monoclonal and Polyclonal Antibodies Research (18 papers)T-cell and B-cell Immunology (9 papers)Enzyme Production and Characterization (9 papers)
Partner nations
SwedenChinaUnited States

In The Last Decade

Bingze Xu

39 papers receiving 1000 citations

Peers

Bingze Xu
Comparison fields: 5 of 97
  • Molecular Biology 406
  • Biotechnology 208
  • Immunology 204
  • Radiology, Nuclear Medicine and Imaging 202
  • Biomedical Engineering 180
Replace Qi Wu with:
Qi Wu China
Enrico Fontanella Italy
Teruo Iwasaki Japan
Ding Liu China
Nina Cimerman Slovenia
Gaetano Leto Italy
Toshiaki Ohara Japan
D.A. Baker Netherlands
Kristine Mann United States
Aaron E. Freeman United States
Bingze Xu relative to Qi Wu China Qi Wu's profile →
Citations per field
00.5×4.9×
Qi Wu · 1×
Citations per year

Countries citing papers authored by Bingze Xu

Since Specialization
Citations

This map shows the geographic impact of Bingze Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingze Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingze Xu more than expected).

Fields of papers citing papers by Bingze Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingze Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingze Xu. The network helps show where Bingze Xu may publish in the future.

Co-authorship network of co-authors of Bingze Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingze Xu. A scholar is included among the top collaborators of Bingze Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingze Xu. Bingze Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 6
3 22
4 8
5 8
6 9
7 17
8 9
9 18
10 19
11 21
12 17
13 3
14 73
15 27
16 14
17 40
18 80
19 61
20 75

About Bingze Xu

Bingze Xu is a scholar working on Immunology and Allergy, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), T-cell and B-cell Immunology (9 papers) and Enzyme Production and Characterization (9 papers). The work is most often cited by research in Biotechnology (208 citations), Rheumatology (160 citations) and Immunology and Allergy (62 citations). Bingze Xu has collaborated with scholars based in Sweden, China and United States. Frequent co-authors include Jan‐Christer Janson, D. Sellos, Rikard Holmdahl, Henrik Stålbrand, Ulrika Broomé, Suchitra Sumitran–Holgersson, Kutty Selva Nandakumar, Ulf Hellman, Bo Ersson and Per Hägglund. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026